188 related articles for article (PubMed ID: 30474825)
1. Methimazole-induced acute pancreatitis: a case report.
Kikuchi I; Miyata N; Yoshimura Y; Miyamoto K; Tachikawa N
Clin J Gastroenterol; 2019 Jun; 12(3):239-242. PubMed ID: 30474825
[TBL] [Abstract][Full Text] [Related]
2. Acute pancreatitis and parotitis induced by methimazole in a patient with Graves' disease.
Taguchi M; Yokota M; Koyano H; Endo Y; Ozawa Y
Clin Endocrinol (Oxf); 1999 Nov; 51(5):667-70. PubMed ID: 10594530
[TBL] [Abstract][Full Text] [Related]
3. Acute pancreatitis induced by methimazole in a patient with Graves' disease.
Yang M; Qu H; Deng HC
Thyroid; 2012 Jan; 22(1):94-6. PubMed ID: 22136208
[TBL] [Abstract][Full Text] [Related]
4. Acute pancreatitis induced by methimazole treatment in a 51-year-old korean man: a case report.
Jung JH; Hahm JR; Jung J; Kim SK; Kim S; Kim KY; Kim BR; Kim HJ; Jeong YY; Kim SJ
J Korean Med Sci; 2014 Aug; 29(8):1170-3. PubMed ID: 25120331
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Graves' hyperthyroidism with thionamides: a position paper on indications and safety in pregnancy.
Tonacchera M; Chiovato L; Bartalena L; Cavaliere AF; Vitti P
J Endocrinol Invest; 2020 Feb; 43(2):257-265. PubMed ID: 31784912
[TBL] [Abstract][Full Text] [Related]
6. [An underestimate iatrogenic effect of antithyroid drugs: Acute pancreatitis].
Ben Hamou A; Banu I; Dupuy O
Presse Med; 2019 Nov; 48(11 Pt 1):1334-1336. PubMed ID: 31727489
[No Abstract] [Full Text] [Related]
7. A case of hypersensitivity syndrome induced by methimazole for Graves' disease.
Ozaki N; Miura Y; Sakakibara A; Oiso Y
Thyroid; 2005 Dec; 15(12):1333-6. PubMed ID: 16405404
[TBL] [Abstract][Full Text] [Related]
8. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
[TBL] [Abstract][Full Text] [Related]
9. Use of antihistamines after serious allergic reaction to methimazole in pediatric Graves' disease.
Toderian AB; Lawson ML
Pediatrics; 2014 May; 133(5):e1401-4. PubMed ID: 24777217
[TBL] [Abstract][Full Text] [Related]
10. The onset of antineutrophil cytoplasmic antibody-associated vasculitis immediately after methimazole was switched to propylthiouracil in a woman with Graves' disease who wished to become pregnant.
Kimura M; Seki T; Ozawa H; Ishihara T; Komatsu M; Tajiri S; Yanagi H; Nishina M; Noh JY; Fukagawa M; Takagi A
Endocr J; 2013; 60(3):383-8. PubMed ID: 23154533
[TBL] [Abstract][Full Text] [Related]
11. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
Kubota S
Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
[TBL] [Abstract][Full Text] [Related]
12. Methimazole-induced aplastic anemia caused by hypocellular bone marrow with plasmacytosis.
Yamamoto A; Katayama Y; Tomiyama K; Hosoai H; Hirata F; Kimura F; Fujita K; Yasuda H
Thyroid; 2004 Mar; 14(3):231-5. PubMed ID: 15072706
[TBL] [Abstract][Full Text] [Related]
13. Polyarthritis caused by methimazole in two Japanese patients with graves' disease.
Nihei H; Tada H; Naruse Y; Izawa M; Kato M; Okuno H; Nakamura A; Ishizu K; Hamajima T; Tajima T
J Clin Res Pediatr Endocrinol; 2013; 5(4):270-2. PubMed ID: 24379039
[TBL] [Abstract][Full Text] [Related]
14. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily.
Takata K; Kubota S; Fukata S; Kudo T; Nishihara E; Ito M; Amino N; Miyauchi A
Thyroid; 2009 Jun; 19(6):559-63. PubMed ID: 19445623
[TBL] [Abstract][Full Text] [Related]
15. The relation of initial methimazole dose to the incidence of methimazole-induced agranulocytosis in patients with Graves' disease.
Tsuboi K; Ueshiba H; Shimojo M; Ishikawa M; Watanabe N; Nagasawa K; Yuasa R; Yoshino G
Endocr J; 2007 Feb; 54(1):39-43. PubMed ID: 17053291
[TBL] [Abstract][Full Text] [Related]
16. Rash and cholestatic liver injury caused by methimazole in a woman with Turner syndrome and Graves's disease: a case report and literature review.
Zeng J; Luo F; Lin Z; Chen Y; Wang X; Song Y
BMC Endocr Disord; 2021 Sep; 21(1):179. PubMed ID: 34479513
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy and adverse effects between methimazole 15 mg+inorganic iodine 38 mg/day and methimazole 30 mg/day as initial therapy for Graves' disease patients with moderate to severe hyperthyroidism.
Sato S; Noh JY; Sato S; Suzuki M; Yasuda S; Matsumoto M; Kunii Y; Mukasa K; Sugino K; Ito K; Nagataki S; Taniyama M
Thyroid; 2015 Jan; 25(1):43-50. PubMed ID: 25178068
[TBL] [Abstract][Full Text] [Related]
18. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease.
Takata K; Amino N; Kubota S; Sasaki I; Nishihara E; Kudo T; Ito M; Fukata S; Miyauchi A
Clin Endocrinol (Oxf); 2010 Jun; 72(6):845-50. PubMed ID: 19912243
[TBL] [Abstract][Full Text] [Related]
19. Methimazole Treatment and Risk of Acute Pancreatitis: A Population-based Cohort Study.
Pecere A; Caputo M; Sarro A; Ucciero A; Zibetti A; Aimaretti G; Marzullo P; Barone-Adesi F
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32813014
[TBL] [Abstract][Full Text] [Related]
20. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
Akin F; Yaylali GF; Bastemir M; Yapar B
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]